(Q53225073)

12 May 2018

review article

1 reference

title

Scopolamine model of dementia: electroencephalogram findings and cognitive performance. (English)

1 reference

12 May 2018

0 references

1 reference

Ebert U

1

1 reference

12 May 2018

Kirch W

series ordinal

2

1 reference

12 May 2018

publication date

1 November 1998

1 reference

12 May 2018

European Journal of Clinical Investigation

published in

1 reference

12 May 2018

volume

28

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

944-949

1 reference

12 May 2018

The cholinergic hypothesis of geriatric memory dysfunction

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

The cholinergic synapse and the site of memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Cholinesterase Inhibition in the Scopolamine Model of Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Models of memory dysfunctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Effects of scopolamine (0.25-0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Cholinergic projections from magnocellular nuclei of the basal forebrain to cortical areas in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Brain cholinergic dysfunction and memory in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Alterations in atropine sites of the brain of rats as a function of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

The functional role of mesotelencephalic dopamine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Excitatory amino acids and memory: evidence from research on Alzheimer's disease and behavioral pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Synergistic anticholinergic and antiserotonergic effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Cholinergic modulation, visual function and Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Studies on muscarinic acetylcholine receptors from mouse brain: Characterization of the interaction with antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Scopolamine effects on memory retention in mice: a model of dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during the performance of a memory task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Pharmacokinetics and related pharmacodynamics of anticholinergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Human flash-VEP and quantitative EEG are independently affected by acute scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

RU 41 656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Modelling dementia: effects of scopolamine on memory and attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Scopolamine effects on visual information processing, attention, and event-related potential map latencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Attenuation of scopolamine-induced amnesia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Scopolamine does not disrupt spatial working memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

Cholinergic 'blockade' as a model of the cognitive deficits in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

A double FDG/PET study of the effects of scopolamine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00393.X

10.1046/J.1365-2362.1998.00393.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

release_srgc6gdmnfe3nf6zzy63xhlonq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/srgc6gdmnfe3nf6zzy63xhlonq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

12 May 2018